SCHEMBL254228

SCHEMBL254228

COC(=O)c1ccc([Si](C)(C)C)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.59
CA2 P00918 3/20 0.59
CA12 O43570 2/20 0.59
CA7 P43166 2/20 0.59
CA9 Q16790 2/20 0.59
CA14 Q9ULX7 2/20 0.59
TDP1 Q9NUW8 1/20 0.59
TSHR P16473 1/20 0.56
MAPT P10636 3/20 0.53
ALDH1A1 P00352 3/20 0.53
LOXL2 Q9Y4K0 1/20 0.52
MAPK1 P28482 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
CASP3 P42574 1/20 0.48
RAB9A P51151 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28452549 0.89 LOXL2 (0.56) CA1CA2CA12CA7CA9
SCHEMBL8351056 0.85 TSHR (0.60) CA1CA2CA12CA7CA9
SCHEMBL16758244 0.85 CA1 (0.57) CA1CA2CA12CA7CA9
SCHEMBL9279020 0.84 LMNA (0.50) CA1CA2CA12CA7CA9
SCHEMBL28993944 0.83 CA1 (0.80) CA1CA2CA12CA7CA9
SCHEMBL23600 0.83 CA1 (0.80) CA1CA2CA12CA7CA9
Methyl Alcohol SCHEMBL28561085 0.81 CA1 (0.76) CA1CA2CA12CA7CA9
SCHEMBL28704033 0.81 CA1 (0.76) CA1CA2CA12CA7CA9
Water SCHEMBL22720573 0.81 CA1 (0.76) CA1CA2CA12CA7CA9
SCHEMBL28531063 0.81 CA1 (0.76) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150284849-A1 LOW-K FILMS WITH ENHANCED CROSSLINKING BY UV CURING APPLIED MATERIALS, INC. (US) 2015-10-08 US disclosed
US-20150284849-A1 LOW-K FILMS WITH ENHANCED CROSSLINKING BY UV CURING APPLIED MATERIALS, INC. (US) 2015-10-08 US disclosed
US-20130065248-A1 REAGENTS AND METHODS FOR SIRTUIN CAPTURE CORNELL UNIVERSITY (US) 2013-03-14 US disclosed
WO-2012031298-A2 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2012-03-08 WO disclosed
US-20090023734-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2009-01-22 US disclosed
US-7282608-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2007-10-16 US disclosed
US-5141932-A Antitumor agents SANDOZ PHARMACEUTICALS CORP. (US) 1992-08-25 US disclosed
US-4992428-A Hypotensive agents, antiallergens, bronchodilator SANDOZ PHARM. CORP. (US) 1991-02-12 US disclosed
US-4910206-A Endotoxin induced lung injury SANDOZ PHARMACEUTICALS CORP. (US) 1990-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023734-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC6 CA1 2287/4885CA2 1762/4885CA12 2624/4885
US-20130065248-A1 REAGENTS AND METHODS FOR SIRTUIN CAPTURE SIRT3, SIRT1, SIRT2 CA1 2867/4885CA2 2770/4885CA12 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.